VHL Deletion Impairs Mammary Alveologenesis but Is Not Sufficient for Mammary Tumorigenesis

American Journal of Pathology - United States
doi 10.2353/ajpath.2010.090310
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PAK1 Hyperactivation Is Sufficient for Mammary Gland Tumor Formation

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Deletion of Cd151 Reduces Mammary Tumorigenesis in the MMTV/PyMT Mouse Model

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

P16INK4a Suppresses BRCA1-deficient Mammary Tumorigenesis

Oncotarget
Oncology
2016English

Vindication Is Sweet, but Not Sufficient

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
1996English

Brca2 Deficiency Does Not Impair Mammary Epithelium Development but Promotes Mammary Adenocarcinoma Formation Inp53+/−Mutant Mice

Cancer Research
Cancer ResearchOncology
2004English

Myc Is Required for Β-Catenin-Mediated Mammary Stem Cell Amplification and Tumorigenesis

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Protein Kinase CK2 in Mammary Gland Tumorigenesis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Stromal Retinoic Acid Receptor Promotes Mammary Gland Tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Conditional Estrogen Receptor Knockout Mouse Model for Studying Mammary Tumorigenesis

2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy